Skip to content

A Study of NB003 in Patients With Advanced Malignancies

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502401-15-00
Acronym
NB003-01
Enrollment
37
Registered
2023-06-26
Start date
2023-10-19
Completion date
2025-08-01
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal stromal tumor, Melanoma, Solid tumors

Interventions

None listed

Sponsors

Ningbo Newbay Technology Development Co. Ltd.
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026